Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB00701_nanopub.RAdXviAITLfaEaJNEdZWc66M8CJgeiRna3EYj1ZyJzttQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB00701 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB00701 label "DDI between Voriconazole and Amprenavir - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of amprenavir by decreasing its metabolism. The serum concentration of voriconazole may be increased by amprenavir. Monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or if doses are changed. [drugbank_resource:DB00582_DB00701]" assertion.
- drugbank_resource:DB00582_DB00701 identifier "drugbank_resource:DB00582_DB00701" assertion.
- drugbank_resource:DB00582_DB00701 title "DDI between Voriconazole and Amprenavir - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of amprenavir by decreasing its metabolism. The serum concentration of voriconazole may be increased by amprenavir. Monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or if doses are changed." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB00701 assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB00701 assertion.